tradingkey.logo
搜尋

Stereotaxis Inc

STXS
添加自選
1.850USD
-0.085-4.38%
收盤 05/15, 16:00美東報價延遲15分鐘
180.81M總市值
虧損本益比TTM

Stereotaxis Inc

1.850
-0.085-4.38%

關於 Stereotaxis Inc 公司

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc簡介

公司代碼STXS
公司名稱Stereotaxis Inc
上市日期Aug 12, 2004
CEOFischel (David Leo)
員工數量139
證券類型Ordinary Share
年結日Aug 12
公司地址710 N Tucker Blvd
城市ST. LOUIS
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編63101
電話13146786100
網址https://www.stereotaxis.com/
公司代碼STXS
上市日期Aug 12, 2004
CEOFischel (David Leo)

Stereotaxis Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
International
19.51M
60.26%
United States
12.87M
39.74%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Dafna Capital Management, LLC
14.03%
Kiani (Joe E)
10.37%
Lagoda Investment Management, L.P.
4.99%
BlackRock Institutional Trust Company, N.A.
3.82%
2012 Revocable Trust of Andrew Redleaf
3.16%
其他
63.64%
持股股東
持股股東
佔比
Dafna Capital Management, LLC
14.03%
Kiani (Joe E)
10.37%
Lagoda Investment Management, L.P.
4.99%
BlackRock Institutional Trust Company, N.A.
3.82%
2012 Revocable Trust of Andrew Redleaf
3.16%
其他
63.64%
股東類型
持股股東
佔比
Investment Advisor
17.49%
Hedge Fund
17.31%
Individual Investor
14.77%
Investment Advisor/Hedge Fund
11.28%
Corporation
3.16%
Bank and Trust
0.65%
Research Firm
0.50%
Pension Fund
0.01%
其他
34.84%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
205
49.70M
50.99%
+2.24M
2025Q4
186
43.95M
47.09%
-1.61M
2025Q3
175
41.68M
45.77%
-4.01M
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Dafna Capital Management, LLC
13.68M
14.07%
--
--
Dec 31, 2025
Kiani (Joe E)
8.86M
9.11%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.86M
5%
+153.80K
+3.27%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.73M
3.83%
+44.20K
+1.20%
Dec 31, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.16%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.88M
2.97%
+30.00K
+1.05%
Dec 31, 2025
Isaac (Paul J)
2.06M
2.12%
+10.00K
+0.49%
Nov 17, 2025
Essex Investment Management Company, LLC
1.56M
1.61%
-36.09K
-2.26%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.57M
1.61%
+55.49K
+3.68%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
佔比0.03%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
iShares Russell 2000 Value ETF
佔比0%
iShares Russell 2000 ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI